(NASDAQ: IRTC) Irhythm Technologies's forecast annual revenue growth rate of 14.61% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.09%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.85%.
Irhythm Technologies's revenue in 2025 is $618,587,000.On average, 5 Wall Street analysts forecast IRTC's revenue for 2025 to be $22,203,448,544, with the lowest IRTC revenue forecast at $22,194,445,618, and the highest IRTC revenue forecast at $22,226,370,885. On average, 5 Wall Street analysts forecast IRTC's revenue for 2026 to be $25,866,074,800, with the lowest IRTC revenue forecast at $25,536,382,568, and the highest IRTC revenue forecast at $26,025,733,061.
In 2027, IRTC is forecast to generate $29,814,719,524 in revenue, with the lowest revenue forecast at $29,429,349,626 and the highest revenue forecast at $30,200,089,422.